Compositions and methods for preventing the recurrence of atrial fibrillation and/or atrial flutter in a human
WO2019147889A1
Compositions and methods for treating atrial fibrillation and/or atrial flutter in a human
WO2015073967A1
Novel metabolites of vanoxerine compounds for the treatment of dopaminergic diseases
WO2014059346A1
Methods for the treatment of conditions involving dopamine through administration of piperazine compounds
US2012028992A1
Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
US2012010216A1
Pharmaceutical compositions containing vanoxerine
US2009143434A1
Methods of using domperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm or heart rate, to prevent recurrence of cardiac arrhythmia and to maintain normal sinus rhythm or heart rate in mammals
US2005208595A1
High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
